Susquehanna International Group, LLP Infla Rx N.V. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
Shares
17 transactions
Others Institutions Holding IFRX
# of Institutions
32Shares Held
18.1MCall Options Held
32.7KPut Options Held
0-
Suvretta Capital Management, LLC New York, NY6.48MShares$5.38 Million0.18% of portfolio
-
683 Capital Management, LLC New York, NY2.48MShares$2.05 Million0.15% of portfolio
-
Ra Capital Management, L.P. Boston, MA1.97MShares$1.64 Million0.03% of portfolio
-
Eversept Partners, LP New York, NY1.64MShares$1.36 Million0.13% of portfolio
-
Morgan Stanley New York, NY1.26MShares$1.05 Million0.0% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $36.7M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...